{
    "Title": "Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit",
    "URL": "https://doi.org/10.1371/journal.pntd.0000372",
    "Published": "February 3, 2009",
    "Subject_Areas": [
        "Trypanosoma cruzi",
        "Trypanosoma",
        "Sterols",
        "Macrophages",
        "Heme",
        "Trypanosoma brucei gambiense",
        "Chagas disease",
        "Protozoan infections"
    ],
    "Authors": {
        "Chiung-Kuang Chen": [
            "Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America"
        ],
        "Patricia S. Doyle": [
            "Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America"
        ],
        "Liudmila V. Yermalitskaya": [
            "Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, United States of America"
        ],
        "Zachary B. Mackey": [
            "Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America"
        ],
        "Kenny K. H. Ang": [
            "Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America"
        ],
        "James H. McKerrow": [
            "Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America"
        ],
        "Larissa M. Podust": [
            "Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America"
        ]
    }
}